down 1.2 this week, been on semaglutide since august. saw some posts about mounjaro and its potential impact on supply chains, wondering if anyone has insights on what this means for our prescriptions 👍
hearing about Mounjaro supply chain concerns after being on semaglutide since august is a familiar worry. The math for individual coverage during a disruption depends heavily on your specific dose cycle timing, not just the general 3-4 week average. It varies enough to matter if you’re planning for an actual gap.
the FDA’s bioequivalence stance will drive most of the supply issues.
fDA bioequivalence drives it.
1.2 this week is solid. The supply chain talk for tirzepatide usually centers on Eli Lilly’s brand-name production capacity, which wouldn’t directly affect sema prescriptions unless there’s an undisclosed shared raw material. Your compounder might have better insight on sema availability.
compounded sema has its own supply chain, usually.